RecruitingNCT05958901
Pulmonary Hypertension Observational Study
A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Enrollment
10,000 participants
Start Date
Jul 12, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.
Eligibility
Min Age: 20 YearsMax Age: 70 Years
Inclusion Criteria2
- PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
- Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
Exclusion Criteria7
- Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
- Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
- Eye surgery in the last three months.
- Retinal detachment myocardial infarction in the last 3 months.
- Admission to hospital for any cardiac condition in the last month.
- Heart rate over 120 beats per minute.
- Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.
Interventions
OTHERpulmonary hypertension
The final outcome observed was a diagnosis of pulmonary hypertension.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05958901
Related Trials
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
NCT0707382036 locations
Development of Novel Physiological CMR Methods in Health and Disease
NCT038540711 location
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT074771971 location
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
NCT017300921 location
Preliminary Human Trials of F230 Tablets
NCT068998151 location